Article
Pusan, South Korea -- Intralesional interferon alfa-2b (Intron-A) can be a useful option for the treatment of rapidly growing keratoacanthomas, Chang-Keun Oh, M.D., Ph.D., said.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.